Blog
72 Articles
Listen to Your Body
When Roxanne Waling discovered she had pancreatic cancer she underwent genetic testing. She found she was a BRCA2 carrier, which influenced her post-treatment decisions about her health.
Reimagining the Possible to Survive Stage IV Pancreatic Cancer
Marisa Harris was given a devastating diagnosis of stage IV pancreatic cancer. She tapped the power within herself, as well as chemotherapy, to become a long-term survivor.
Genetic Testing Can Help Those You Love
Dr. Fay Kastrinos, director of the Muzzi Mirza Pancreatic Cancer Prevention and Genetics Program at Columbia University Medical Center, explains the value of genetic testing for cancer prevention and treatment.
Genomic Testing of Pancreatic Tumor Leads to an Important Discovery
Connie Waxman learned the value of palliative care after chemotherapy, radiation, and a pancreatectomy for pancreatic cancer; then she had genomic testing.
Molecular Profiling: Getting to Know Your Tumor
Dr. Johanna Bendell explains the value of molecular profiling, which can indicate the best type of chemotherapy for your tumor.
The ABCs of Genetic Testing
There are a number of different genetic mutations that can cause familial pancreatic cancer. This article explains some of the most common ones.
Before You Leap: Genetic Testing for Pancreatic Cancer
Genetic counselor Megan Frone outlines the advantages of genetic testing when there is a family history of pancreatic cancer.
Advocating For My Own Future
Kay Kays is a long-term survivor of pancreatic cancer who has learned to advocate for herself to get the treatments she needs.
Frequently Asked Questions About Pancreatic Cancer
Have you or someone you love just been diagnosed with pancreatic cancer? Learn some basic facts about this disease from our FAQ.
Tumor Genetics Research Brings Some Answers for Families at High Risk
Professor Gloria Peterson of the Mayo Clinic is working on tumor genetics to help make early detection of pancreatic cancer a reality.
Far More Time than I Originally Expected
After a Whipple procedure, SBRT, and chemotherapy, Robert Glazier is staying informed about treatment options for pancreatic cancer.
Taking Nothing For Granted
After Whipple surgery and chemoradiation, Susan Zbacnik had molecular profiling, genetic testing, and joined an Immunotherapy clinical trial.
An Immunotherapy Game Changer
Immunotherapy with Keytruda (pembrolizumab) is approved for use in cancer patients with certain genetic defects in their tumors.
A Maintenance Trial for Patients with BRCA or PALB2 Mutations
A clinical trial examines whether the PARP inhibitor rucaparib can work as a maintenance drug for pancreatic cancer patients with BRCA or PALB2 mutations.
Treating BRCA-Negative Pancreatic Cancer Patients with a Family Cancer History Similar to BRCA Carriers
A clinical trial looks at the effectiveness of a PARP inhibitor in BRCA-negative pancreatic cancer patients with a family history BRCA-type cancers.